Swapping vs Dose Optimization in Patients With IBD Losing Response to Adalimumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug Levels
Inflamm. Bowel Dis. 2022 May 04;28(5)720-727, X Roblin, C Genin, S Nancey, N Williet, P Veyrard, G Boschetti, JM Phelip, AE Berger, M Killian, L Waeckel, B Flourie, S PaulFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.